Nogapendekin alfa Reference: HY-P99759 Nogapendekin alfa is a superagonist of IL-15. Nogapendekin alfa promotes the proliferation and viability of immune cells. Nogapendekin alfa combines with Inbakicept (HY-P99661) at a ratio of 2:1, to form ALT-803, an IL-15 cytokine antibody fusion protein. ALT-803 reduces tumor burden by activation of NK cells and CD8+ T cells.
oYo-Link® Tetrazine Antibody Labeling Kit - Labels 1mg Reference: AT3004-1000 Research Use Only Applications: Click Chemistry with TCO (trans-cyclooctene)-bound molecules. oYo-Link® Tetrazine allows for the site-specific labeling of oYo-Link®-compatible antibodies with up to two tetrazine labels per antibody for subsequent copper-free click chemistry reactions with TCO (trans-cyclooctene)-bound molecules. oYo-Link® Tetrazine limits the attachment of the tetrazine labels to the heavy chains of the antibody and therefore ensures that the tetrazine label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 tetrazine labels to be attached per antibody, providing precise antibody-conjugate ratios. The antibody labeling procedure simply requires mixing oYo-Link® Tetrazine with the desired antibody followed by photocrosslinking with non-damaging black light (365 nm). Photocrosslinking can be carried out in most buffers, including those containing amine-containing molecules (e.g. TRIS, glycine) or storage proteins (see Buffer Compatibility Table). Requirements: To label your compatible antibodies with oYo-Link®, you will need a Light Source emitting at 365nm (6-10W). Use your own Compatible Device from our list or purchase AlphaThera's LED Photo-Crosslinking Device. Technical Support: For questions concerning compatibility or click-chemistry procedure email support@alphathera.com
Frovocimab Reference: HY-P99626 Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9.
oYo-Link® Tetrazine Antibody Labeling Kit - Labels 100ug mIgG1 Ab Reference: AT3004-mIgG1-100 Research Use Only Applications: Click Chemistry with TCO (trans-cyclooctene)-bound molecules. oYo-Link® Tetrazine allows for the site-specific labeling of oYo-Link®-compatible antibodies with up to two tetrazine labels per antibody for subsequent copper-free click chemistry reactions with TCO (trans-cyclooctene)-bound molecules. oYo-Link® Tetrazine limits the attachment of the tetrazine labels to the heavy chains of the antibody and therefore ensures that the tetrazine label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 tetrazine labels to be attached per antibody, providing precise antibody-conjugate ratios. The antibody labeling procedure simply requires mixing oYo-Link® Tetrazine with the desired antibody followed by photocrosslinking with non-damaging black light (365 nm). Photocrosslinking can be carried out in most buffers, including those containing amine-containing molecules (e.g. TRIS, glycine) or storage proteins (see Buffer Compatibility Table). Requirements: To label your compatible antibodies with oYo-Link®, you will need a Light Source emitting at 365nm (6-10W). Use your own Compatible Device from our list or purchase AlphaThera's LED Photo-Crosslinking Device. Technical Support: For questions concerning compatibility or click-chemistry procedure email support@alphathera.com
Urelumab Reference: HY-P99055 Urelumab, a fully human, non-ligand binding, CD137 agonist IgG4 monoclonal antibody, enhances T-cell and natural killer-cell antitumor activity, and may enhance cytotoxic activity of Rituximab. Urelumab can be used for the research of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and other types of non-Hodgkin lymphoma (NHL).
oYo-Link® Tetrazine Antibody Labeling Kit- Labels 500ug mIgG1 Ab Reference: AT3004-mIgG1-500 Research Use Only Applications: Click Chemistry with TCO (trans-cyclooctene)-bound molecules. oYo-Link® Tetrazine allows for the site-specific labeling of oYo-Link®-compatible antibodies with up to two tetrazine labels per antibody for subsequent copper-free click chemistry reactions with TCO (trans-cyclooctene)-bound molecules. oYo-Link® Tetrazine limits the attachment of the tetrazine labels to the heavy chains of the antibody and therefore ensures that the tetrazine label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 tetrazine labels to be attached per antibody, providing precise antibody-conjugate ratios. The antibody labeling procedure simply requires mixing oYo-Link® Tetrazine with the desired antibody followed by photocrosslinking with non-damaging black light (365 nm). Photocrosslinking can be carried out in most buffers, including those containing amine-containing molecules (e.g. TRIS, glycine) or storage proteins (see Buffer Compatibility Table). Requirements: To label your compatible antibodies with oYo-Link®, you will need a Light Source emitting at 365nm (6-10W). Use your own Compatible Device from our list or purchase AlphaThera's LED Photo-Crosslinking Device. Technical Support: For questions concerning compatibility or click-chemistry procedure email support@alphathera.com
Ascrinvacumab Reference: HY-P99353 Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC).